High-Acuity Hospital-at-Home for Complex Exacerbations: A Critical Appraisal of the Surveillance-to-Escalation Gap
Journal of Health Reports and Technology · 31.07.2026 · 12 (3)
DOI: 10.5812/jhrt-174894 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Health Reports and Technology, online erschienen am 31.07.2026. Verfasst von Ehsan Mohsenikhah. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Context
Hospital-at-Home (HaH) no longer denotes substitution for low-risk admissions. Under the United States Acute Hospital Care at Home waiver and English virtual wards, patients with decompensated heart failure, chronic obstructive pulmonary disease exacerbations, and severe sepsis now receive inpatient-level care at home with remote monitoring. Programs report low rates of escalation and mortality; however, randomized evidence at this level of acuity remains limited and is largely influenced by selection. This review aimed to determine whether the surveillance-and-response architecture used to justify higher-acuity home care has been validated in current settings and to grade, link by link, the directness of the supporting evidence. Evidence Acquisition: In this structured narrative review, PubMed/MEDLINE, Embase, the Cochrane Library, and Scopus were searched from 1 January 2019 to 31 August 2026; the gray literature was last checked at the same time. Validation was conceptualized as a chain of six claims: measurement, signal, algorithm, clinical action, escalation performance, and system-level effect. Each claim was assigned one of four prespecified directness grades and appraised for design limitations, selection, precision, and applicability; evidence on substitutive HaH was reported separately.
Results
Forty-three sources were synthesized. In a noninferiority trial (n = 1,150), 30-day death or unplanned readmission occurred in 17.3% versus 19.8% (odds ratio 0.85, 95% confidence interval [CI] 0.63 - 1.14). Waiver programs reported escalation in 7.2% of episodes and unanticipated mortality of 0.36%, whereas observational waiver data showed an adjusted in-hospital mortality odds ratio of 0.09 (95% CI 0.06 - 0.16), which is too large to reflect a treatment effect. Continuous inpatient monitoring showed no significant reduction in intensive care transfer, rapid-response activation, or mortality, and no trial has compared monitoring intensities within HaH. No association was demonstrated within substitutive HaH at contemporary acuity: three studies relied on indirect evidence, one association was plausible but unmeasured, escalation timeliness was unknown, and system-level effects were observed only in selected lower-acuity populations.
Conclusions
The evidence indicates a surveillance-to-escalation gap without demonstrated harm; however, absence of evidence is not evidence of ineffectiveness or unacceptable safety, and the implications are therefore provisional rather than prohibitive. Home intravenous decongestion for selected patients with heart failure is the best-supported indication; further expansion should preferably occur within prospective evaluations with prespecified safety stopping rules.
Zitieren
APA
Mohsenikhah, E. (2026). High-Acuity Hospital-at-Home for Complex Exacerbations: A Critical Appraisal of the Surveillance-to-Escalation Gap. Journal of Health Reports and Technology, 12(3). https://doi.org/10.5812/jhrt-174894
Vancouver
Mohsenikhah E. High-Acuity Hospital-at-Home for Complex Exacerbations: A Critical Appraisal of the Surveillance-to-Escalation Gap. Journal of Health Reports and Technology. 2026;12(3). doi:10.5812/jhrt-174894
BibTeX
@article{Mohsenikhah2026,
author = {Mohsenikhah, Ehsan},
title = {High-Acuity Hospital-at-Home for Complex Exacerbations: A Critical Appraisal of the Surveillance-to-Escalation Gap},
journal = {Journal of Health Reports and Technology},
year = {2026},
volume = {12},
number = {3},
doi = {10.5812/jhrt-174894}
}
EUVIMED